Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with epilepsy
- People who are currently prescribed medicine to help control seizures
- People who belong to a racial or ethnic group that has historically been underrepresented in research or healthcare, or who are on a low income (for example, those whose situation makes them eligible for public assistance or government-subsidised health coverage)
- Young people aged 14–17 who are willing to participate with agreement (assent), and who have a parent or legal authorised representative available to receive app notifications during the study
- People aged 18–24 who are able to give their own informed consent to participate
- People who can read, speak, and write in English
- People who live in Florida
- People who receive medical care on an outpatient basis (meaning they are not admitted to a hospital to receive care)
Who may not be able to join:
- People who do not own a mobile device with internet access
- People who have a history of severe intellectual disability
- People who are unable to use a mobile device, whether by keyboard or touchscreen
- People who currently live in an inpatient setting (such as a hospital or residential care facility)
- Adults who are not able to give their own informed consent
- People who are pregnant
- People who are currently incarcerated
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Michelle Tall, PhD, RN, FAES, University of Central Florida
Phone: 4077970555
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Examine the effect of Medilepsy® with and without responsible AI design on medication adherence.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.